BillionToOne

BillionToOne is a precision diagnostics company transforming prenatal and oncology care through our proprietary QCT™ technology.

By quantifying cell-free DNA with unmatched accuracy, we deliver advanced genetic insights that empower earlier, more precise clinical decisions. Our UNITY and Northstar tests bring innovation to every stage of patient care—from non-invasive prenatal screening to liquid biopsy applications in oncology. 

As the fastest-growing prenatal lab in the country, with over 1 million prenatal tests performed, we’re redefining clinical standards and delivering the clarity patients and providers need at life’s most critical moments.